Patients who had a series of abnormal lung CT scans were more likely to abstain from smoking and to remain smoke-free after three years than those with fewer abnormal scans, according to a study published in the May 15 issue of Cancer.
Patients who had a series of abnormal lung CT scans were more likely to abstain from smoking and to remain smoke-free after three years than those with fewer abnormal scans, according to a study published in the May 15 issue of Cancer.
Researchers at the Mayo Clinic in Rochester, MN, conducted a longitudinal study of current and former smokers. Among patients who had an abnormal exam in each of three years, 41.9% reported smoking abstinence. Cessation rates decreased with fewer abnormal exams.
Several factors contributed to smoking abstinence among baseline smokers: older age, worse baseline pulmonary function, and previous-year abnormal CT exam.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.